C3H mice were found to be much less responsive to tumor induction in an initiation/promotion protocol than CD-I mice. To explore the difference in strain sensitivity, the frequencies of cells resistant to calcium-induced terminal differentiation(calcium resistant cells, CRCs) were measured in C3H, CD-I, and SENCAR mice. The induced frequencies after 7,12-dimethylbenz(a)anthracene(DMBA) treatment were similar in all three strains, ranging from 0.70 to 0.83 × 10-6, and suggested that the differences in tumor outcome were more likely related to promotion than initiation. Spontaneous frequencies ranged from 0.73 to 3.75 CRCs per mouse or 0.07 to 0.22 CRC/106 cells. The spontaneous frequency in the C3H mouse was significantly less than that in the other two strains. However, the spontaneous mutation rates were found to be similar in all three strains, ranging from 0.05 to 0.07 × 10-6 and it was found that the keratinocytes, which were resistant to terminal differentiation, were independently distributed in C3H but not in CD-I and SENCAR mice. These data are consistent with the hypothesis that clonal expansion occurs in CD-I and SENCAR but not C3H mice. Conceivably the greater propensity for clonal expansion in CD-I and SENCAR than in C3H mice is related to the greater likelihood of tumor formation as well as the more rapid development of tumors in the former strains.
Berenblum, I., N. Haran-Ghera, and N. Trainin. 1958. An experimental analysis of the “hair cycle effect” in mouse carcinogenesis. Br. J. Cancer12:402–413.
2.
Bradley, J. V.1968. Distribution free statistical tests, 195–203. Englewood Cliffs, NJ: Prentice-Hall.
3.
Breslow, N. E.1984. Extra-Poisson variation in log-linear models. Appl. Stat.33:33–44.
4.
Breslow, N. E.1990. Test of hypotheses in overdispersed Poisson regression and other quasi-likelihood models. J. Am. Stat. Assoc.85:565–571.
5.
Breslow, N. E., and Day, N. E.1987. Statistical methods in cancer research, Vol. II, The design and analysis of cohort studies. Oxford, UK: Oxford University Press.
6.
Chasey, K., and R. McKee. 1993. Evaluation of the dermal carcinogenicity of lubricant base oils by the mouse skin painting bioassay and other proposed methods. J. Appl. Toxicol.13:57–65.
7.
DiGiovanni, J., A. Imamoto, M. Naito, S. Walker, L. Beltrain, K. Chenicek, and L. Skow. 1992. Further genetic analysis of skin tumor promoter susceptibility using inbred and recombinant inbred mice. Carcinogenesis13:525–531.
8.
DiGiovanni, J., W. Prichett, P. Decina, Diamond P., and L. Diamond. 1984. DBA/2 mice are as sensitive as SENCAR mice to skin tumor promotion by 12-o-tetradecanoylphorbol-13-acetate. Carcinogenesis5:1493–1498.
9.
Elmets, C., S. Zaidi, D. Bickers, and H. Mukhtar. 1992. Immunogenetic influences on the initiation stage of the cutaneous chemical carcinogenesis pathway. Cancer Res.52:6106–6109.
10.
Green, M. H. L., S. K. Cook, J. Cole, and C. F. Arlett. 1990. A statistical analysis of the third UKEMS collaborative trial. Mutagenesis5:(Suppl.) 71–84.
11.
Greenhalgh, D. A., D. J. Welty, J. E. Strickland, and S. H. Yuspa. 1989. Spontaneous Ha-ras gene activation in cultured primary murine keratinocytes: Consequences of Ha-ras gene. Activation in malignant conversion and malignant progression. Mol. Carcinogenesis2:199–207.
12.
Heddle, J. A., J. D. Gingerich, C. Urlando, M. Pagura, P. Shepson, and M. A. Khan. 1992. Detection of somatic mutation in vivo in lung fibroblasts, I. Spontaneous frequencies in Chinese hamsters and F344 rats. Mutation. Res.272:195–203.
13.
Kawarmira, H., J. Strickland, and S. Yuspa. 1985. Association of resistance to differentiation with initiation of carcinogenesis in adult mouse epidermal cells. Cancer Res.45:2748–2752.
14.
Kinoshita, N., and H. Gelboin. 1972. The role of aryl hydrocarbon hydroxylase in 7,12-dimethylbenz(a)anthracene skin tumorigenesis: On the mechanism of 7,8-benzoflavone inhibition of tumorigenesis. Cancer Res.32:1329–1339.
15.
Kulesz-Martin, M., A. Kilkenny, K. Holbrook, V. Digernes, and S. Yuspa. 1983. Properties of carcinogen altered mouse epidermal cells resistant to calcium-induced terminal differentiation. Carcinogenesis4: 1367–1377.
16.
Leroux, B. G., and D. Krewski. 1993. AMESETT: A microcomputer program for fitting linear-exponential dose-response models in the Ames Salmonella assay. Environ. Mol. Mutagen22:78–84.
17.
Luria, S. E., and M. Delbruck. 1943. Mutations of bacteria from virus sensitivity to virus resistance. Genetics28:491–511.
18.
McKee, R. H., and J. J. Freeman. 1993. Dermal carcinogenicity studies of petroleum-derived materials. In Health risk assessment: Dermal and inhalation exposure and absorption of toxicants, eds. R. G. Wang, J. B. Knaak, and H. I. Maibach, 263–274. Boca Raton, FL: CRC Press.
19.
McKee, R., R. Plutnick, and R. Przygoda. 1989. The carcinogenic initiating and promoting properties of a lightly refined paraffinic oil. Fund am. Appl. Toxicol.12:748–756.
20.
Miller, D., A. Vieje, C. Aldaz, C. Conti, and T. Slaga. 1987. Terminal differentiation-resistant epidermal cells in mice undergoing two-stage carcinogenesis. Cancer Res.47:1935–1940.
21.
Miller, D., A. Vieje, J. Rotstein, C. Aldaz, C. Conti, and T. Slaga. 1989. Induction of terminal differentiation-resistant epidermal cells in mouse skin and in papillomas by different initiators during two-stage carcinogenesis. Cancer Res.49:410–414.
22.
Morris, R. J., K. C. Tacker, J. K. Baldwin, S. M. Fisher, and T. J. Slaga. 1987. A new medium for primary cultures of adult murine epidermal cells: Application to experimental carcinogenesis. Cancer Lett.34:297–304.
23.
Nesnow, S., H. Bergman, and T. Slaga. 1986. Comparison of the tumorigenic response of SENCAR and C57BL/6 mice to benzo(a)pyrene and the inter-experimental variability over a three-year period. Environ. Health Perspect.68:19–25.
24.
Pelling, J. R.Neades, R., and J. Strawhecker. 1988. Epidermal papillomas and carcinomas induced in uninitiated mouse skin by tumor promoters alone contain a point mutation in the 1st codon of the Ha-ras oncogene. Carcinogenesis9:665–667.
25.
Przygoda, R., J. Freeman, J. S. Katz, and R. Mckee. 1994. Increased frequency of resistance to terminal differentiation in C3H mouse cells produced by genotoxic but not nongenotoxic carcinogens. Fundam. Appl. Toxicol.23:261–267.
26.
Reiners. J., S. Nesnow, and T. Slaga. 1984. Murine susceptibility to two-stage carcinogenesis is influenced by the agent used for promotion. Carcinogenesis5:301–307.
27.
Shapiro, S. S., and M. B. Wilk. 1965. An analysis of variance test for normality (complete samples). Biometrika52:591–611.
28.
Snedecor, G. W., and W. G. Cochran. 1971. Statistical methods, 215–221. Ames IA: Iowa State University Press.
29.
Stenback, F.1980. Skin carcinogenesis as a model system: Observations on species, strain, and tissue sensitivity to 7,12-dimethylbenz(a)anthracene and topical promotion with 12-O-tetradecanoylphorbol-l 3-acetate. Acta Pharmacol. Toxicol.46:89–97.
30.
United States Department of Health, Education and Welfare (DHEW). 1985. Guide for the care and use of laboratory animals. DHEW Publication Number (NIH) 85-23. Washington, DC: DHEW.
31.
Yuspa, S., and D. L. Morgan. 1981. Mouse skin cells resistant to terminal differentiation associated with initiation of carcinogenesis. Nature293:72–74.
